The present disclosure provides for a rhodium-catalyzed oxidative arene alkenylation from arenes and styrenes to prepare stilbene and stilbene derivatives. For example, the present disclosure provides for method of making arenes or substituted arenes, in particular stilbene and stilbene derivatives, from a reaction of an optionally substituted arene and/or optionally substituted styrene. The reaction includes a Rh catalyst or Rh pre-catalyst material and an oxidant, where the Rh catalyst or Rh catalyst formed Rh pre-catalyst material selectively functionalizes CH bond on the arene compound (e.g., benzene or substituted benzene).

The present disclosure provides for a rhodium-catalyzed oxidative arene alkenylation from arenes and styrenes to prepare stilbene and stilbene derivatives. For example, the present disclosure provides for method of making arenes or substituted arenes, in particular stilbene and stilbene derivatives, from a reaction of an optionally substituted arene and/or optionally substituted styrene. The reaction includes a Rh catalyst or Rh pre-catalyst material and an oxidant, where the Rh catalyst or Rh catalyst formed Rh pre-catalyst material selectively functionalizes CH bond on the arene compound (e.g., benzene or substituted benzene).

Disclosed herein are embodiments of nanohoop compounds and conjugates thereof that can be used myriad biological applications. The nanohoop compounds described herein can exhibit beneficial properties that are useful in biotechnology, such as a fluorescent tag, probe, or label.

Disclosed herein are embodiments of nanohoop compounds and conjugates thereof that can be used myriad biological applications. The nanohoop compounds described herein can exhibit beneficial properties that are useful in biotechnology, such as a fluorescent tag, probe, or label.

A compound having formula (I) or (II) for use inhibiting Bax mediated cell death and/or apoptosis.

##STR00001##

A compound having formula (I) or (II) for use inhibiting Bax mediated cell death and/or apoptosis.

##STR00001##

The present disclosure generally relates to a process for converting a hydrocarbon feed including introducing a hydrocarbon feed comprising a C.sub.1+ alkane to a catalyst composition in a reactor, the catalyst composition comprising a Group 6-Group 15 metal supported on a support; and irradiating the hydrocarbon feed and the catalyst composition with electromagnetic energy in the reactor at reactor conditions to produce a product comprising a C.sub.2+ alkane, wherein the C.sub.2+ alkane of the product is heavier than the C.sub.1+ alkane in the hydrocarbon feed.

The present disclosure generally relates to a process for converting a hydrocarbon feed including introducing a hydrocarbon feed comprising a C.sub.1+ alkane to a catalyst composition in a reactor, the catalyst composition comprising a Group 6-Group 15 metal supported on a support; and irradiating the hydrocarbon feed and the catalyst composition with electromagnetic energy in the reactor at reactor conditions to produce a product comprising a C.sub.2+ alkane, wherein the C.sub.2+ alkane of the product is heavier than the C.sub.1+ alkane in the hydrocarbon feed.

The present disclosure is directed to novel derivatives of naturally occurring cannabinoids, methods of making them, compositions comprising them, and methods for using them.

The invention relates to bimesogenic compounds of formula I

##STR00001##

wherein R.sup.11, R.sup.12, MG.sup.11, MG.sup.12 and CG.sup.1 have the meaning given in claim 1, to the use of bimesogenic compounds of formula I in liquid crystal media and particular to flexoelectric liquid crystal devices comprising a liquid crystal medium according to the present invention.